Literature DB >> 10350036

Olanzapine: weight gain and therapeutic efficacy.

S Gupta, T Droney, S Al-Samarrai, P Keller, B Frank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10350036     DOI： 10.1097/00004714-199906000-00014

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  16 in total

Review 1.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

Review 2.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.

Authors:  Aung Naing; Shalini Dalal; Maen Abdelrahim; Jennifer Wheler; Kenneth Hess; Siqing Fu; David S Hong; Filip Janku; Gerald S Falchook; Alyson Ilustre; Fengying Ouyang; Razelle Kurzrock
Journal:  Support Care Cancer       Date:  2015-02-15       Impact factor: 3.603

Review 4.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Bodyweight gain with atypical antipsychotics. A comparative review.

Authors:  T Wetterling
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

Review 6.  Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.

Authors:  J M Russell; J A Mackell
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  The association between weight change and symptom reduction in the CATIE schizophrenia trial.

Authors:  Eric Hermes; Henry Nasrallah; Vicki Davis; Jonathan Meyer; Joseph McEvoy; Donald Goff; Sonia Davis; T Scott Stroup; Marvin Swartz; Jeffrey Lieberman; Robert Rosenheck
Journal:  Schizophr Res       Date:  2011-02-21       Impact factor: 4.939

8.  Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

9.  Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.

Authors:  Michal Taler; Israel Vered; Rea Globus; Liat Shbiro; Abraham Weizman; Aron Weller; Irit Gil-Ad
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

10.  Topiramate in Bipolar and Schizoaffective Disorders: Weight Loss and Efficacy.

Authors:  Sanjay Gupta; Prakash S. Masand; Bradford L. Frank; Kari L. Lockwood; Peggy L. Keller
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.